No evidence of cerebral oedema in severe acute mountain sickness

Cephalalgia

Volumn 24, Issue 1, 2004, Pages 66-71

  Fischer, R ^a   Vollmar, C ^a   Thiere, M ^a   Born, C ^a   Leitl, M ^a   Pfluger, T ^a   Huber, R M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute mountain sickness; Cerebral oedema; Diffusion weighted imaging; High altitude

Indexed keywords

ACETAZOLAMIDE; PLACEBO; THEOPHYLLINE; VASODILATOR AGENT;

ADULT; ALTITUDE; ALTITUDE DISEASE; ARTICLE; BRAIN; BRAIN EDEMA; CEREBROSPINAL FLUID; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIFFUSION WEIGHTED IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HYPOXIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ACETAZOLAMIDE; ALTITUDE SICKNESS; BRAIN; BRAIN EDEMA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PLACEBO EFFECT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 0347634397     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00619.x     Document Type: Article

References (16)

1. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345:107-14.
2. Matsuzawa Y, Kobayashi T, Fujimoto K, Shinozaki S, Yoshikawa S. Cerebral edema in acute mountain sickness. In: Reeves JT, Sekiguchi M, editors, High-Altitude Medicine. Matsumoto, Japan: Shinshu University, 1992:300-4.
3. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging, clinical correlation and pathophysiology. J Am Med Assoc 1998; 280:1920-5.
4. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 2001; 204:3161-70.
5. Roach RC, Bärtsch P, Oelz O, Hackett PH. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, editors, Hypoxia and Molecular Medicine. Burlington, VT: Queen City Press, 1993:272-4.
6. Sampson JB, Cymerman A, Burse RL, Maher JT, Rock PB. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med 1983; 54:1063-73.
7. Levine BD, Yoshimura K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321:1707-13.
8. Grissom CK, Roach RC, Sarnquist FH, Hackett PH. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992; 116:461-5.
9. Hackett PH, Roach RC. Medical therapy of altitude illness. Ann Emerg Med 1987; 16:980-6.
10. Fischer R, Lang SM, Steiner U, Toepfer M, Hautmann H, Pongratz H et al. Theophylline improves acute mountain sickness. Eur Respir J 2000; 15:123-7.
11. Kerttula T, Kaukinen S, Seppala E, Riutta A, Mucha I, Ylitalo P et al. Theophylline infusion modulates prostaglandin and leukotriene production in man. Prostaglandins Leukot Essent Fatty Acids 1997; 57:555-60.
12. Baumgartner RW, Spyridopoulos I, Bartsch P, Maggiorini M, Oelz O. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J Appl Physiol 1999; 86:1578-82.
13. Morocz IA, Zientara GP, Gudbjartsson H, Muza S, Lyons T, Rock PB et al. Volume trie quantification of brain swelling after hypobaric hypoxia exposure. Exp Neurol 2001; 168:96-104.
14. Weed L. Some limitations of the Monro-Kellie hypothesis. Arch Surg 1929; 18:1049-68.
15. Sanchez DR, Moskowitz MA. High altitude headache. Lessons from headaches at sea level. Adv Exp Med Biol 1999; 474:145-53.
16. Bowton DL, Stump DA, Anderson R. Effect of chronic theophylline therapy on brain blood flow and function in adult asthmatics. Am J Respir Crit Care Med 1994; 150:1002-5.